Cancer/testis antigens as biomarker and target for the diagnosis, prognosis, and therapy of lung cancer

HIGHLIGHTS

  • who: Ping Yang from the Department of Pathophysiology, School of Medicine, Nantong University, Nantong, China, Cyrus Tang Hematology have published the article: Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer, in the Journal: (JOURNAL)
  • what: The main reasons for the poor outcome of lung cancer are the lack of a highly specific and sensitive biomarker for early diagnosis of the disease and the absence of effective drugs for lung cancer therapy . Under this scenario, the authors propose several new strategies for CTA-targeted genetic and epigenetic editing . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?